Bicycle Therapeutics (BCYC) Change in Account Payables (2018 - 2026)

Bicycle Therapeutics' Change in Account Payables history runs 9 years deep, the most recent figure standing at -$3.8 million for Q1 2026.

• Quarterly Change in Account Payables rose 23.53% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.7 million (down 242.29% YoY) and the FY2025 annual result came in at -$6.9 million, down 322.0% from the prior year.
• Change in Account Payables was -$3.8 million for Q1 2026 at Bicycle Therapeutics, down from -$2.9 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $10.7 million in Q4 2024 and bottomed at -$5.9 million in Q1 2024.
• A 5-year average of $173470.6 and a median of -$431000.0 in 2024 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2023 — Change in Account Payables tumbled 684.71% — and 2025, when it soared 1515.08%.
• Bicycle Therapeutics' Change in Account Payables stood at -$2.4 million in 2022, then soared by 275.82% to $4.2 million in 2023, then jumped by 156.49% to $10.7 million in 2024, then slumped by 126.96% to -$2.9 million in 2025, then slumped by 33.22% to -$3.8 million in 2026.
• Business Quant data shows BCYC's Change in Account Payables at -$3.8 million in Q1 2026, -$2.9 million in Q4 2025, and -$5.1 million in Q3 2025.